SARS-CoV-2 Antibody Durability

Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.

Event Details:SARS-CoV-2 Antibody DurabilityDate(s):

FREE Webinar

Monday, October 26, 2020
2:30 - 4:00 PM, Eastern Time

COVID-19 vaccine development depends on identifying potent neutralizing antibodies. Recent research studies suggest that neutralizing antibodies found in the blood of recovered COVID-19 patients decay rapidly and the level of antibody protection may correlate with infection severity. In this webinar brought to you by The Scientist, scientists studying the SARS-CoV-2 immune response will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.

Topics to be covered

Register Now

Meet the Speakers:

Jennifer Gommerman, PhD
Professor, Department of Immunology
Canada Research Chair in Tissue Specific Immunity
Associate Chair, Graduate Studies, Department of Immunology
University of Toronto

Marion Pepper, PhD
Associate Professor, Department of Immunology
University of Washington

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member? Login Here